Literature DB >> 16353969

Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms.

Aditya S Tatavarti1, Raafat Fahmy, Huiquan Wu, Ajaz S Hussain, William Marnane, Dennis Bensley, Gary Hollenbeck, Stephen W Hoag.   

Abstract

The goal of this study was to assess the utility of near infrared (NIR) spectroscopy for the determination of content uniformity, tablet crushing strength (tablet hardness), and dissolution rate in sulfamethazine veterinary bolus dosage forms. A formulation containing sulfamethazine, corn starch, and magnesium stearate was employed. The formulations were wet granulated with a 10% (wt/vol) starch paste in a high shear granulator and dried at 60 degrees C in a convection tray dryer. The tablets were compressed on a Stokes B2 rotary tablet press running at 30 rpm. Each sample was scanned in reflectance mode in the wavelengths of the NIR region. Principal component analysis (PCA) of the NIR tablet spectra and the neat raw materials indicated that the scores of the first 2 principal components were highly correlated with the chemical and physical attributes. Based on the PCA model, the significant wavelengths for sulfamethazine are 1514, (1660-1694), 2000, 2050, 2150, 2175, 2225, and 2275 nm; for corn starch are 1974, 2100, and 2325 nm; and for magnesium stearate are 2325 and 2375 nm. In addition, the loadings show large negative peaks around the water band regions ( approximately 1420 and 1940 nm), indicating that the partial least squares (PLS) models could be affected by product water content. A simple linear regression model was able to predict content uniformity with a correlation coefficient of 0.986 at 1656 nm; the use of a PLS regression model, with 3 factors, had an r (2) of 0.9496 and a standard error of calibration of 0.0316. The PLS validation set had an r (2) of 0.9662 and a standard error of 0.0354. PLS calibration models, based on tablet absorbance data, could successfully predict tablet crushing strength and dissolution in spite of varying active pharmaceutical ingredient (API) levels. Prediction plots based on these PLS models yielded correlation coefficients of 0.84 and 0.92 on independent validation sets for crushing strength and Q(120) (percentage dissolved in 120 minutes), respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353969      PMCID: PMC2750416          DOI: 10.1208/pt060115

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles.

Authors:  John P Higgins; Steven M Arrivo; Gert Thurau; Robert L Green; William Bowen; Andrew Lange; Allen C Templeton; Denise L Thomas; Robert A Reed
Journal:  Anal Chem       Date:  2003-04-15       Impact factor: 6.986

2.  Chemometric evaluation of pharmaceutical properties of antipyrine granules by near-infrared spectroscopy.

Authors:  Makoto Otsuka; Yoshifumi Mouri; Yoshihisa Matsuda
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

3.  Validation of a near-infrared transmission spectroscopic procedure. Part B: Application to alternate content uniformity and release assay methods for pharmaceutical solid dosage forms.

Authors:  Gary E Ritchie; Robert W Roller; Emil W Ciurczak; Howard Mark; Cindy Tso; Stacy A MacDonald
Journal:  J Pharm Biomed Anal       Date:  2002-06-20       Impact factor: 3.935

4.  Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.

Authors:  Makoto Otsuka; Fumie Kato; Yoshihisa Matsuda; Yukihiro Ozaki
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

5.  Nondestructive near-infrared analysis of intact tablets for determination of degradation products.

Authors:  J K Drennen; R A Lodder
Journal:  J Pharm Sci       Date:  1990-07       Impact factor: 3.534

6.  Characteristics of hydroxypropyl methylcellulose influencing compactibility and prediction of particle and tablet properties by infrared spectroscopy.

Authors:  Christina Gustafsson; Christer Nyström; Helena Lennholm; Maria C Bonferoni; Carla M Caramella
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

7.  In-line moisture measurement during granulation with a four-wavelength near infrared sensor: an evaluation of particle size and binder effects.

Authors:  J Rantanen; E Räsänen; J Tenhunen; M Känsäkoski; J Mannermaa; J Yliruusi
Journal:  Eur J Pharm Biopharm       Date:  2000-09       Impact factor: 5.571

8.  Water sorption and near IR spectroscopy to study the differences between microcrystalline cellulose and silicified microcrystalline cellulose before and after wet granulation.

Authors:  G Buckton; E Yonemochi; W L Yoon; A C Moffat
Journal:  Int J Pharm       Date:  1999-04-20       Impact factor: 5.875

9.  A study of the molecular properties of water in hydrated mannitol.

Authors:  Helen M Derbyshire; Yuri Feldman; Chris R Bland; Joanne Broadhead; Geoff Smith
Journal:  J Pharm Sci       Date:  2002-04       Impact factor: 3.534

10.  Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil- and water-soluble multivitamin with minerals tablets.

Authors:  Jianping Du; Stephen W Hoag
Journal:  Drug Dev Ind Pharm       Date:  2003-11       Impact factor: 3.225

View more
  2 in total

1.  NIR spectroscopy applications in the development of a compacted multiparticulate system for modified release.

Authors:  Stuart L Cantor; Stephen W Hoag; Christopher D Ellison; Mansoor A Khan; Robbe C Lyon
Journal:  AAPS PharmSciTech       Date:  2011-01-15       Impact factor: 3.246

2.  Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets.

Authors:  Ravikanth Kona; Raafat M Fahmy; Gregg Claycamp; James E Polli; Marilyn Martinez; Stephen W Hoag
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.